electroCore (ECOR) Other financing activities (2017 - 2025)
electroCore's quarterly Other financing activities came in at $38000.0 in Q1 2025, up 3900.0% quarter-over-quarter from -$1000.0 in Q3 2024.
electroCore has reported Other financing activities for 7 years, with the latest figure at $38000.0 in Q1 2025.
- For the quarter ending Q1 2025, Other financing activities changed N/A year-over-year to $38000.0; the trailing twelve-month figure through Dec 2025 stood at $37000.0 (down 98.88% YoY), and the FY2025 full-year result was $95000.0, down 59.05% from the prior year.
- Other financing activities for Q1 2025 stood at $38000.0, up from -$1000.0 in the prior quarter.
- The five-year high for Other financing activities was $3.3 million in Q4 2021, with the low at -$1000.0 in Q3 2024.
- Average Other financing activities over 3 years is $556666.7, with a median of $89.5 recorded in 2021.
- Peak annual rise in Other financing activities reached 207.07% in 2021, while the deepest fall reached 1.1% in 2021.
- Tracing ECOR's Other financing activities over 3 years: stood at $3.3 million in 2021, then tumbled by 100.03% to -$1000.0 in 2024, then surged by 3900.0% to $38000.0 in 2025.
- The last three Other financing activities figures came in at $38000.0 (Q1 2025), -$1000.0 (Q3 2024), and $3.3 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 38,000.00 |
| Mar 31, 2025 | 38,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Dec 31, 2021 | 3.30 Mn |
| Dec 31, 2021 | 3.30 Mn |
| Sep 30, 2021 | -100.00 |
| Sep 30, 2021 | -100.00 |
| Jun 30, 2021 | 197.00 |
| Jun 30, 2021 | 197.00 |
| Mar 31, 2021 | -18.00 |
| Mar 31, 2021 | -18.00 |
| Dec 31, 2020 | 3.27 Mn |
| Dec 31, 2020 | 3.27 Mn |
| Sep 30, 2020 | -255.00 |
| Sep 30, 2020 | -255.00 |
| Jun 30, 2020 | -184.00 |
| Jun 30, 2020 | -184.00 |
| Mar 31, 2020 | -125.00 |
| Mar 31, 2020 | -125.00 |
| Sep 30, 2019 | -28.00 |
| Sep 30, 2019 | -28.00 |
| Mar 31, 2019 | 183.00 |
| Mar 31, 2019 | 183.00 |
| Jun 30, 2018 | 12.20 Mn |
| Jun 30, 2018 | 12.20 Mn |
| Mar 31, 2018 | 525,231.00 |
| Mar 31, 2018 | 525,231.00 |
| Dec 31, 2017 | 373,304.00 |
| Dec 31, 2017 | 373,304.00 |
| Sep 30, 2017 | -232,845.00 |
| Sep 30, 2017 | -232,845.00 |